Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05519878 · ClinicalTrials.gov registry record · NA

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

A NA study of Prostate Carcinoma and Bladder Carcinoma, sponsored by City of Hope Medical Center.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT05519878: Recruiting NA study of Prostate Carcinoma and Bladder Carcinoma, sponsored by City of Hope Medical Center.

NCT05519878 is a NA study of Prostate Carcinoma and Bladder Carcinoma that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 224 participants, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05519878, a NA study of Prostate Carcinoma and Bladder Carcinoma, is actively recruiting participants, sponsored by City of Hope Medical Center.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.

Primary Outcome

The effects of light therapy and occupational therapy (OT) on FACIT will be evaluated by comparing light therapy to no-light therapy and comparing occupational therapy to no-occupational therapy. Analysis of variance test will be used for the factorial comparisons, with a two-sided statistical significance level (alpha = 0.05). The interaction between occupational therapy and light therapy will be explored (to understand whether the effect of light therapy \[if any\] on FACIT would change with o

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • BEHAVIORAL Occupational Therapy
  • DEVICE Bright White Light Therapy

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2022-11-29
Est. Completion 2027-05-25
Phase NA
City of Hope Medical Center

582 total trials

What NCT05519878 shows while recruiting

NCT05519878 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (85% lower).

The record links to 4 conditions, with Prostate Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT05519878 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05519878 about?

NCT05519878 is a clinical study titled "Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers". This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a l...

What is the current status of trial NCT05519878?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2022-11-29. Estimated completion is 2027-05-25.

What conditions does trial NCT05519878 study?

This clinical trial studies the following conditions: Prostate Carcinoma, Bladder Carcinoma, Kidney Carcinoma, Genitourinary System Neoplasm.

What interventions are being tested in trial NCT05519878?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Occupational Therapy (BEHAVIORAL), Bright White Light Therapy (DEVICE).

Who is sponsoring clinical trial NCT05519878?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05519878 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05519878's enrollment target sits among peer trials

224 16th of 59 higher than 44 of 59 other Prostate Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05559671 · 224 participants · Phase 4

    Safety of the Herpes Zoster Subunit Vaccine in Lupus

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05519878, the US trial registry maintained by the National Library of Medicine. NCT05519878 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.